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Background: Diagnosis and management of NEC is based on clinical, radiological, and
laboratory findings. Discrimination of pathogens for an improved understanding of NEC
in preterm infants and NEC in infants with congenital heart disease has been previously
discussed and enables evaluation of further NEC biomarkers.
Patients and Methods: Within a study period of 11 years (2008–2019), we identified
107 patients with a diagnosis of NEC at our primary care center. Thirty-six out of 54
patients suffering from NEC in high Bell stages who underwent surgery met inclusion
criteria. These patients were classified according to their cardiac status, and analyses of
clinical factors influencing NEC were conducted. Additionally, clinical factors associated
with a fulminant course of NEC were examined. Univariable and multivariable analyses
were performed.
Results: The study populations consisted of 12 preterm infants with NEC but without
patent ductus arteriosus (PT-NEC), seven preterm infants with NEC and patent ductus
arteriosus (PDA-NEC), and 17 infants with NEC and congenital heart disease (CHD-NEC).
Blood flow in intestinal vessels was impaired in infants with PDA-NEC and CDH-NEC.
Therefore, we used logistic regression to compare PDA-NEC and CDH-NEC infants with
PT-NEC infants: positive bacterial culture of intraoperative swabs (p = 0.0199; odds
ratio: 21.9) and macroscopic intestinal necrosis (p = 0.0033; odds ratio: 43.5) were
observed more frequently in the first group. Furthermore, multiple regression analysis
determined the NEC localization (p = 0.0243) as a significant factor correlated with a
fulminant course. Compared to a NEC exclusively localized in the colon, there is a 5.8-fold
increased risk of a fulminant course when the small intestine is affected and a 42-fold
increase of risk when both small intestine and colon were affected.
Conclusion: An early diagnosis and timely surgical intervention of NEC, especially in
infants with PDA and CDH may be considered to avoid major bowel necrosis (resulting
in loss of intestinal tissue) and multiple operations.
Keywords: necrotizing enterocolitis, NEC, congenital heart disease, patent ductus arteriosus, fulminant NEC
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INTRODUCTION
Necrotizing enterocolitis (NEC) is a major cause of morbidity
and mortality in preterm infants with a case fatality rate of 15–
30% (1), leading to profound intestinal injuries and resulting in
multiple long-term disabilities, such as intestinal strictures, short
bowel syndrome, or neurodevelopmental delay. Incidence rates
are estimated at 3–15% (2), whereas 7–20% of all NEC cases occur
in term infants (3). Velazco et al. (4) identified CHD in almost
20% of NEC patients with a birth weight of more than 2,500 g.
NEC prevalence in patients with congenital heart disease (CHD)
is estimated at 3.7% (5). Nowadays, incidence rates are decreasing
due to specialized preventive care (2). However, mortality rates
remain stable.
Optimum treatment remains a challenge and requires
interdisciplinary management. Decisions on appropriate empiric
antibiotic regimen/strict bowel rest with gastric decompression
in addition to timing of surgery are, thus, discussed individually
in each case (6). In 20–40% of all cases, surgical intervention
results from a lack of clinical improvement under conservative
therapy. In cases of pneumoperitoneum or other evidence of
intestinal perforation, surgical intervention is generally indicated
and, thus, recommended as ultima ratio (7).
Pathogenesis of NEC is considered a multifactorial process.
However, a central hypothesis is discussed regarding an initial
insult (intestinal ischemia, bacterial overgrowth) leading to loss
of intestinal mucosal integrity (6). Inflammatory processes by
baseline elevation of circulating endotoxin and proinflammatory
cytokines (e.g., sepsis, systemic inflammation, shock) are the
possible cause of further injuries, such as bowel necrosis. In
recent research, separation of pathophysiology, incidence, and
mortality of NEC in CHD patients and NEC in preterm
infants was brought into focus (8–10). Accordingly, impaired
intestinal perfusion and reduced intestinal arterial oxygen
saturation in infants with cyanotic heart disease outrank
classical causes in pathogenesis and are the leading causes
for its development and mortality. Patent ductus arteriosus
(PDA), on the other hand, causes diastolic dysfunction,
leading to heart failure, organ hypoperfusion, and oxygen
deficiency in target tissues owing to the steal phenomenon,
which is defined as a decreased tissue perfusion caused by
diastolic backflow to areas of lower resistance despite their
normal arterial oxygen saturation (3, 11). Until now, there
is no explicit differentiation in literature between NEC in
preterm infants with PDA and NEC in infants without PDA
concerning characterization of NEC manifestation and further
clinical course.
Based on this knowledge of a distinguished pathophysiology,
we hypothesized that the three different patient subgroups
(preterm infants without PDA, preterm infants with PDA, and
infants with CDH) with advanced NEC show different clinical
characteristics. The purpose of this study is to describe the
manifestation and clinical course of NEC within these three
different patient subgroups in order to achieve therapeutic
improvement. A further goal was to develop markers indicating
a fulminant course of NEC.
PATIENTS AND METHODS
Data Collection and Inclusion Criteria
This is a retrospective study carried out on all infants with clinical
signs of NEC treated in our perinatal center over a period of 11
years from January 2008 to July 2019. The study was approved by
the local ethics committee in accordance with the declaration of
Helsinki (1964) and its later amendments.
We collected all data for infants with the diagnosis of NEC
within this period. Data were extracted from medical reports,
including all clinical parameters and therapeutic measures. NEC
was diagnosed and staged by modified Bell’s criteria (12). The
indication for surgery was based on signs of intestinal perforation
in diagnostics or the infant’s deterioration during conservative
therapy, including antibiotic treatment and exclusive parenteral
nutrition. In the latter, velocity of progression into a septic
clinical picture led to indication for immediate surgery in cases
of a high possibility of unstoppable intestinal necrosis and
irreversible deterioration without surgery. The following criteria
were included in the diagnosis: changes in blood pressure and
respiratory parameters, need of fluids to maintain circulation,
need for catecholamines, and advanced mechanical ventilation
to achieve satisfying oxygen levels. There were no differences
in surgical indication between preterm patients and patients
with cardiac concomitant diseases as the same surgical team led
diagnostic and therapeutic management in all patients within the
whole study time.
The focus of our analysis is surgically treated patients
with confirmed diagnosis due to histologic findings. Therefore,
all conservatively successfully treated patients were excluded
from the study. Furthermore, patients were excluded if NEC
was not confirmed intraoperatively and in cases of co-
occurrence with volvulus or abdominal wall defects (exact
discrimination of causing pathogenesis was not possible in
these cases). Figure 1 illustrates the study design and shows
the allocation of patients to the different subgroups. The
three different subgroups regarding cardiac status comprised
preterm infants without any cardiac pathological findings,
preterm infants with PDA, and infants with congenital cardiac
malformations. The subgroup of cardiac malformations included
all septal defects, pulmonary stenosis/atresia, transposition of
great arteries, and hypoplastic left heart syndrome as well as
tetralogy of Fallot, univentricular malformations, and Ebstein’s
disease. Congenital heart defects oftentimes consist of multiple
malformations; therefore, patients were assigned to groups
of their leading diagnosis. Diagnosis of reduced intestinal
perfusion in patients with PDA or CHD was made on the
basis of sonography and doppler. In all of these patients, an
impact on intestinal diastolic flow could be seen (reduced
or even reversed end-diastolic flow). In contrast, in almost
all of the patients of the preterm subgroup (11/12 patients),
direct or indirect signs of a sufficient intestinal perfusion could
be confirmed.
The second subgroup analysis addressed the fulminant
courses of NEC. Surgically treated patients were subdivided
retrospectively into patients with fulminant NEC and infants
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FIGURE 1 | Study design and composition of study cohort.
with non-fulminant NEC on the basis of clinical experience as
there is no consistent definition in literature. Fulminant NEC
was retrospectively defined as NEC with extensive necrosis,
requiring multiple surgical interventions or intestinal resection
of >20 cm.
Statistical Analysis and Structure of
Analysis
Data were recorded as quantitative variables or categorical
factors and analyzed according to subgroups. SAS software
release 9.4 (SAS Institute Inc., Cary, NC, USA) was used for all
statistical analyses.
In order to compare the three subgroups, Kruskal–Wallis
tests were used for quantitative data. For qualitative data,
chi-squared test or Fisher’s exact test have been performed
as appropriate. In the case of a statistically significant test
result, comparisons between two groups were conducted using
Mann–Whitney U test, chi-square, or Fisher’s exact test,
respectively, using Bonferroni correction to adjust for multiple
comparisons. Furthermore, multiple logistic regression analysis
was performed to compare preterm infants without PDA (PT-
NEC) with patients with cardiac malformation (PDA-NEC
and CHD-NEC subgroups) as well as to compare infants
with fulminant NEC vs. infants with non-fulminant NEC.
Backward selection was used in order to find an optimal
combination of variables explaining the relevant binary outcome.
In general, a test result with a p-value < 0.05 was considered
statistically significant.
RESULTS
Demographic Baseline Data
Over the study period of 11 years, we treated a total of 107
patients with NEC in our clinic. In 50% of cases, patients with
NEC needed surgical intervention (n = 54). After exclusion
of 18 patients according to exclusion criteria, all analyses were
conducted for the remaining 36 patients. The study population
consisted of 12 preterm infants with NEC but without patent
ductus arteriosus (PT-NEC), seven preterm infants with NEC
and PDA (PDA-NEC), and 17 NEC cases with CHD (CHD-NEC,
see Figure 1). Baseline demographics of the included patients
are shown in Table 1. Median gestational age at birth was 31.3
weeks (post-menstrual age) with amedian birth weight of 1,825 g.
APGAR values were measured at 1, 5, and 10min after birth with
a median of 6.0 (range: 0–10), 8.0 (range: 3–10), and 8.5 (range
3–10), respectively. Initial respiratory support using continuous
positive airway pressure (CPAP) had to be applied in 19 cases
(53%); primary mechanical ventilation was initiated in four
newborns (11%). Nutrition was started in all infants. Fourteen
patients out of 36 cases (39%) were fed with mainly human milk
or human milk exclusively. The median age at NEC onset was
18.0 days of life (range: 3–105). Increased gastric residuals and
abdominal distension were the initial signs of beginning NEC in
a great majority of cases. Early symptoms included abdominal
distension in 97% of cases (n= 35), whereas hematochezia (31%,
n = 11) and abdominal erythema (17%, n = 6) could only be
observed in a few cases.
Due to the study design, high Bell stages are characteristic of
the study population (12). Most patients were assigned to the
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TABLE 1 | Patients’ demographical data.
Parameter
Sex [n (%)] n = 36
Male 25 (69%)
Female 11 (31%)
Gestational age [weeks] [median (range)] 31.3 (23.6–41.4)
Weight at birth [g] [median (range)] 1,825 (550–3,680)
Classification in analysis subgroups [n (%)] n = 36
PT-NEC 12 (33%)
PDA-NEC 7 (20%)
CHD-NEC 17 (47%)
Leading cardiac malformations [n (%)] n = 17
Atrial/Ventricular septal defect 1 (3%)
Pulmonary stenosis/atresia 4 (11%)
Double inlet left ventricle 1 (3%)
Transposition of great arteries (with functionally univentricular
heart)
5 (14%)
Hypoplastic left heart syndrome 3 (8%)
Tetralogy of Fallot 2 (6%)
Ebstein’s disease 1 (3%)
(Postnatal) Respiratory support [n (%)] n = 34
Spontaneous breathing 11 (31%)
Mechanical ventilation 4 (11%)
CPAP 19 (53%)
CPAP before diagnosis [n (%)] n = 36
No 14 (39%)
Yes 22 (61%)
Postnatal infection [n (%)] n = 35
No 20 (56%)
Yes 15 (42%)
Human milk [n (%)] n = 36
Human milk exclusively 8 (22%)
Mainly human milk 6 (17%)
Mainly formula, but human milk included 5 (14%)
No human milk 17 (47%)
Outcome: short bowel syndrome [n (%)] n = 36
No 29 (81%)
Yes 7 (19%)
Outcome: survival [n (%)] n = 36
No 10 (28%)
Yes 26 (72%)
group of modified Bell’s stage III (n = 22, 61%) and IIb (n =
11, 31%), whereas no patient with NEC stage I/IIa was included
in this analysis. In 92% of patients, pneumoperitoneum, portal
venous gas, pneumatosis intestinalis, fixed dilated intestinal
loops, or other generalized intestinal dilatation could be seen in
either sonographic or radiological imaging diagnostics (n = 33).
In 40% of cases, sonographic or radiological signs of an intestinal
perforation could be observed. In the remaining patients (60%),
immediate surgery was conducted in cases of a high possibility
of unstoppable intestinal necrosis and irreversible deterioration
without surgery.
The surgical approach comprised open intestinal exploration
in all cases and additional intestinal resection if needed. Surgical
treatment with primary peritoneal drainage was not performed
in any case. In 58% of infants with fulminant NEC, diagnosis
of short bowel syndrome led to long-term parenteral nutrition
(seven out of 12 patients).
Cardiac malformations in our cohort are demonstrated in
Table 1. Hence, 14 out of 24 patients with cardiac malformations
suffered from a cyanotic congenital heart defect (58%). All
patients developed NEC prior to cardiac surgery. Overall survival
rate within the study population was 72% (deaths in 10 out of 36
surgically treated NEC patients).
Analysis of Influence of Cardiac Status
Univariable Analysis of Clinical Factors Within
Subgroups
Supplementary Table 1 demonstrates the comparison of clinical
parameters between the three different NEC groups. Table 2
enhances the statistical tests by demonstrating the results of
pairwise comparisons between PT-NEC infants with PDA-
NEC infants, PT-NEC infants with CHD-NEC infants, and
PDA-NEC infants with CHD-NEC infants in the case of
significant differences between the three groups (indicated in
Supplementary Table 1).
Infants with CDH and preterm infants with PDA showed
reduced intestinal blood flow due to PDA or cardiac
malformation in comparison to preterm infants without
PDA as described in previous studies. Therefore, we compared
CDH-NEC infants/PDA-NEC infants with PT-NEC infants
using univariable analysis (Table 3).
Comparison of Clinical Factors Between Infants With
Impaired Intestinal Perfusion (CDH-NEC, PDA-NEC)
and Preterm Infants Without PDA (PT-NEC) Using
Multivariable Analysis
Logistic regression was used in order to analyze several
parameters simultaneously. Detection of bacteria in
intraoperatively performed swabs by bacterial culture could
be seen more frequently in patients with PDA-NEC and
CDH-NEC compared to preterm infants without PDA (p =
0.0199; odds ratio: 21.9), indicating an elevated amount of
bacteria migration through the intestinal wall. Furthermore,
logistic regression revealed significantly increased macroscopic
intestinal necrosis (p = 0.0033; odds ratio: 43.5) in CDH- and
PDA-NEC groups. Again, this fact additionally represents an
advanced stage of NEC with macroscopic necrosis. The area
under the curve (AUC) as a measure of goodness of fit is 0.913.
This indicates a quite reliable statistical model.
Analysis of Fulminant NEC
Univariable Analysis of Fulminant NEC
We suggest improving clinical assessment of NEC by defining
fulminant NEC retrospectively in cases of multiple surgical
interventions and/or an intestinal resection >20 cm in order to
identify confounding variables and clinical associations with a
high-risk clinical course and poor outcome. Table 4 depicts the
results of univariable analysis in consideration of comparison
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TABLE 2 | Clinical characteristics of patients divided in cardiac subgroups and analyzed between two groups.
PT-NEC CHD-NEC PT-NEC PDA-NEC CHD-NEC PDA-NEC
Gestational age
[weeks; median (range)]
31.1 (25.3–35.6) 38.2 (26.7–41.4) 0.0024 31.1 (25.3–35.6) 26.9 (23.6–29.1) 0.0060 38.2 (26.7–41.4) 26.9 (23.6–29.1) 0.0018
Weight at birth [g;
median (range)]
1,670 (770–2,280) 2,580 (680–3,680) 0.0111 1,670 (770–2,280) 840 (550–1,220) 0.0381 2,580 (680–3,680) 840 (550–1,220) 0.0027
Postnatal in-fection [n
(%)]
n = 12 n = 16 0.0162 n = 12 n = 7 1.0000 n = 16 n = 7 0.0321
No 4 (33%) 14 (82%) 4 (33%) 2 (29%) 14 (82%) 2 (29%)
Yes 8 (67%) 2 (12%) 8 (67%) 5 (71%) 2 (12%) 5 (71%)
Prostaglandin E1 [n (%)] n = 12 n = 17 0.0012 n = 12 n = 7 nn n = 17 n = 7 0.0177
No 12 (100%) 6 (35%) 12 (100%) 7 (100%) 6 (35%) 7 (100%)
Yes 0 11 (65%) 0 0 11 (65%) 0
COX2-In-hibitors [n (%)] n = 12 n = 17 nn n = 12 n = 7 0.0054 n = 17 n = 7 0.0015
No 12 (100%) 17 (100%) 12 (100%) 2 (29%) 17 (100%) 2 (29%)
Yes 0 0 0 5 (71%) 0 5 (71%)
Fresh frozen plasma [n
(%)]
n = 12 n = 17 0.0126 n = 12 n = 7 1.0000 n = 17 n = 7 0.0699
No 10 (83%) 5 (29%) 10 (83%) 6 (86%) 5 (29%) 6 (86%)
Yes 2 (17%) 12 (71%) 2 (17%) 1 (14%) 12 (71%) 1 (14%)
CPAP before diagnosis
[n (%)]
n = 12 n = 17 0.0126 n = 12 n = 7 1.0000 n = 17 n = 7 0.0138
No 2 (17%) 12 (71%) 2 (17%) 0 12 (71%) 0
Yes 10 (83%) 5 (29%) 10 (83%) 7 (100%) 5 (29%) 7 (100%)
Proof of bacteria
intra-operatively [n (%)]
n = 12 n = 17 0.0573 n = 12 n = 7 0.0285 n = 17 n = 7 1.0000
No 11 (92%) 8 (47%) 1 (92%) 2 (29%) 8 (47%) 2 (29%)
Yes 1 (8%) 9 (53%) 1 (8%) 5 (71%) 9 (53%) 5 (71%)
Age at surgery [days;
median (range)]
11 (3–49) 24(3–105) 0.1872 11 (3–49) 25 (11–81) 0.0921 24 (3–105) 25 (11–81) 1.0000
Intestinal necrosis [n
(%)]
n = 12 n = 17 0.0027 n = 12 n = 7 0.0285 n = 17 n = 7 1.0000
No 11 (92%) 5 (29%) 11 (92%) 2 (29%) 5 (29%) 2 (29%)
Yes 1 (8%) 12 (71%) 1 (8%) 5 (71%) 12 (71%) 5 (71%)
Localization of NEC [n
(%)]
n = 12 n = 17 0.4740 n = 12 n = 7 0.4356 n = 17 n = 7 0.0483
Small bowels 7 (58%) 4 (23%) 7 (58%) 3 (43%) 4 (23%) 3 (43%)
Colon 3 (25%) 10 (59%) 3 (25%) 0 10 (59%) 0
Both localizations 2 (17%) 3 (18%) 2 (17%) 4 (57%) 3 (18%) 4 (57%)
Outcome: survival [n
(%)]
n = 12 n = 17 0.0573 n = 12 n = 7 1.0000 n = 17 n = 7 0.0669
No 1 (8%) 9 (53%) 1 (8%) 0 9 (53%) 0
Yes 11 (92%) 8 (47%) 11 (92%) 7 (100%) 8 (47%) 7 (100%)
Tests were conducted if global analysis (Supplementary Table 1) showed statistically significant results after adjustment by Bonferroni–Holm. Statistical testing could be conducted in
12 preterm infants without patent ductus arteriosus (PT-NEC), 17 infants with congenital heart disease (CHD-NEC), and seven preterm infants with patent ductus arteriosus (PDA-NEC).
Due to small numbers, statistical tests were not conductible for every constellation (nn = non nominatus). Significant results have been highlighted (bold values).
between infants with fulminant NEC and infants with non-
fulminant NEC.
Multivariable Analysis of Fulminant NEC
Multiple regression analysis revealed the localization of NEC (p=
0.0243) and the number of surgeries (p= 0.0450) asmost relevant
factors associated with fulminant NEC. The risk of a fulminant
NEC—compared to an NEC localized exclusively in the colon—
is 5.8-fold increased in cases of affliction of the small intestine
and 42-fold increased when both small intestine and colon are
affected. This model showed an AUC of 0.847. Bowel loss and
persistent intestinal failure could be seen especially in fulminant
NEC cases.
DISCUSSION
Most recently, discrimination of NEC in preterm infants and
NEC in infants with concomitant cardiac malformations has
been the subject of intensive research. Previous studies have
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TABLE 3 | Comparison between infants with impaired intestinal perfusion
(CDH-NEC, PDA-NEC) and preterm infants without PDA (PT-NEC).
Classification by cardiac status
Parameter PT-NEC CHD/PDA-NEC p-value
Sex [n (%)] n = 12 n = 24 1.0000
Male 8 (67%) 17 (71%)
Female 4 (33%) 7 (29%)
Gestational age [weeks;
median (range)]
31.1
(25.3–35.6)
36.3 (23.6–41.4) 0.2171
Weight at birth [g; median
(range)]
1670
(770–2280)
2080 (550–3680) 0.2877
CPAP before diagnosis [n (%)] n = 12 n = 24 0.0765
No 2 (17%) 12 (50%)
Yes 10 (83%) 12 (50%)
Postnatal infection [n (%)] n = 12 n = 23 0.0398
No 4 (33%) 16 (67%)
Yes 8 (67%) 7 (29%)
Prostaglandin E1 [n (%)] n = 12 n = 24 0.0059
No 12 (100%) 13 (54%)
Yes 0 11 (46%)
Fresh frozen plasma
transfusion [n (%)]
n = 12 n = 24 0.0314
No 10 (83%) 11 (46%)
Yes 2 (17%) 13 (54%)
Catecholamines [n (%)] n = 12 n = 24 0.2357
No 7 (58%) 9 (37%)
Yes 5 (42%) 15 (63%)
Human milk [n (%)] n = 12 n = 24 0.4929
Human milk exclusively 2 (17%) 6 (25%)
Mainly human milk 1 (8%) 5 (21%)
Mainly formula, but human
milk included
1 (8%) 4 (17%)
No human milk 8 (67%) 9 (37%)
CRP at diagnosis [mg/l;
median (range)]
8.0
(0.6–259.0)
55.7 (0.3–239.0) 0.0674
Proof of bacteria
intraoperatively [n (%)]
n = 12 n = 24 0.0041
No 11 (92%) 10 (42%)
Yes 1 (8%) 14 (58%)
Age at surgery [days; median
(range)]
11 (3–49) 25 (3–105) 0.0224
Intestinal necrosis [n (%)] n = 12 n = 24 0.0004
No 11 (92%) 7 (29%)
Yes 1 (8%) 17 (71%)
Intestinal perforation [n (%)] n = 12 n = 24 0.2357
No 7 (58%) 9 (37%)
Yes 5 (42%) 15 (63%)
Localization of NEC [n (%)]
Small bowels
n = 12
7 (58%)
n = 24
7 (29%)
Colon 3 (25%) 10 (42%) 0.3270
Both localizations 2 (17%) 7 (29%)
Number of needed surgeries
[n (%)]
1 (1–4) 1 (1–3) 0.2808
(Continued)
TABLE 3 | Continued
Classification by cardiac status
Parameter PT-NEC CHD/PDA-NEC p-value
Outcome: short bowel
syndrome [n (%)]
n = 12 n = 24 0.6639
No 9 (75%) 20 (83%)
Yes 3 (25%) 4 (17%)
Outcome: survival [n (%)] n = 12 n = 24 0.1149
No 1 (8%) 9 (37%)
Yes 11 (92%) 15 (63%)
Fulminant NEC [n (%)] n = 12 n = 24 0.7091
No 9 (75%) 15 (63%)
Yes 3 (25%) 9 (37%)
Significant results have been highlighted (bold values).
demonstrated the association of NEC with CHD, presenting
controversial results on incidence, associations, and mortality
(3, 8, 10, 13–16) with various population sizes and subgroup
analyses. Siano et al. (8) reported that congenital heart defects
could be identified as a risk factor for the incidence of NEC
(OR 1.849) and increased mortality rates (OR 3.4). Lau et al.
(16) associated patients with ductal dependent congenital heart
disease with an elevated risk of NEC compared to their
counterparts. Pathogenesis in both PT-NEC and CHD subgroups
is suggested to be distinct, whereas the clinical course is equalized,
and symptoms are thought to be similar (17). Focus on clinical
differences in the course of diagnosis and therapy between
cardiogenic NEC and classic NEC has not been scientifically
discussed so far but is crucial for improvement of knowledge
regarding this neonatal disease.
Although important differences in the clinical presentation of
NEC in full-term infants in comparison to preterm infants have
been reported (18), yet little is known about the involvement of
single clinical variables on the clinical course of NEC. Therefore,
the results of our retrospective study at a primary care center
represent additional clinical aspects to the development of NEC.
So far, only Bubberman et al. (9) have presented results on
the involvement of clinical variables within a recent study,
comparing 18 CHD-NEC patients and 36 selected PT-NEC
patients. Results of this analysis confirm the hypothesis of a
varying pathophysiology of PT-NEC and CHD-NEC patients.
This is primarily explained by the fact that the colon was
significantly more often involved in CHD-NEC vs. PT-NEC
(86 vs. 33%, p = 0.03) according to mesenteric hypoxia in
CHD patients. Our observations of the univariable analysis
are consistent with these findings. This is mainly ascribed to
previously explained pathophysiological mechanisms of blood
circulation, steal phenomenon, and increased susceptibility of the
colon to ischemia resulting from inferior collateral blood supply
compared to other intestinal regions (19).
In contrast, we see that aggravated forms of reduced
perfusions within a fulminant NEC show mainly an impact on
the small intestine in the course of time. The small intestinemight
be influenced more extensively on the basis of its larger size in
comparison to the colon. Therefore, reduction of diastolic flow
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TABLE 4 | Comparison of infants with and without fulminant NEC.
Parameter NF-NEC F-NEC p-value
Gestational age [weeks;
median (range)]
34.1 (24.4–41.4) 29.5 (23.6–39.0) 0.1751
Weight at birth [g; median
(range)]
1,940 (600–3,300) 1,185 (550–3,680) 0.4175
Postnatal infection [n (%)] n = 23 n = 12 0.4109
No 12 (50%) 8 (67%)
Yes 11 (46%) 4 (33%)
Cardiac defect [n (%)] n = 24 n = 12 0.4201
No cardiac defect 9 (37%) 3 (25%)
Cardiac malformation 12 (50%) 5 (42%)
PDA 3 (13%) 4 (33%)
Prostaglandin E1 [n (%)] n = 24 n = 12 0.2681
No 15 (63%) 10 (83%)
Yes 9 (37%) 2 (17%)
COX2-Inhibitors [n (%)] n = 24 n = 12 0.0336
No 23 (96%) 8 (67%)
Yes 1 (4%) 4 (33%)
Catecholamines [n (%)] n = 24 n = 12 0.8125
No 11 (46%) 5 (42%)
Yes 13 (54%) 7 (58%)
Human milk [n (%)] n = 24 n = 12 0.5262
Human milk exclusively 6 (25%) 2 (17%)
Mainly human milk 5 (21%) 1 (8%)
Mainly formula, but
human milk included
2 (8%) 3 (25%)
No human milk 11 (46%) 6 (50%)
X-ray pathologies [n (%)] n = 18 n = 10 1.0000
No 1 (4%) 1 (8%)
Yes 17 (71%) 9 (75%)
Age at surgery [days;
median (range)]
15 (3–105) 27 (7–81) 0.1350
Number of needed
surgeries [n (%)]
n = 24 n = 12 0.0680
1 (1–3) 1.5 (1–4)
Localization NEC [n (%)] n = 22 n = 12 0.0144
Small bowels 9 (37%) 5 (42%)
Colon 12 (50%) 1 (8%)
Both 3 (13%) 6 (50%)
Outcome: short bowel
syndrome [n (%)]
n = 24 n = 12 <0.0001
No 24 (100%) 5 (42%)
Yes 0 7 (58%)
Significant results have been highlighted (bold values).
might impact larger intestinal parts. Additionally, specific factors,
such as decreased FOXP3+ regulatory T-cell levels or increased
levels of platelet-activating factor and increased expression of its
receptor in the ileum, have been identified in the development of
NEC and could be specifically associated with the small intestine
(20). Finally, the influence of meconium in the small intestine
might be evaluated further as a basis for intestinal dilatation,
impaired intestinal motility, and resulting critical perfusion. The
combination of all of these specific factors and the impaired
regulation of microcirculatory perfusion of the gut in preterm
infants puts the small intestine with its comparably large size at a
special risk in the development of NEC and its advanced courses.
Secondarily, Bubberman et al. (9) suggest further
differentiation of pathophysiology of NEC between the
subgroups based on a primary inflammatory process to assess
disease severity. Accordingly, Bubberman et al. (10) stated
an association of PT-NEC patients and elevated CRP values.
However, this association remains to be controversially discussed.
Within our study population, we see 13 preterm infants with
postnatal infections (13/15 cases with postnatal infections),
which are all early onset and show a mild clinical course.
Association of elevated CRP values in the development of NEC
could not be confirmed. We propose to differ strictly between
postnatal infections in neonates and intraoperative positive
swabs on the basis of peritonitis as presented in advanced cases
of NEC in CHD patients in our study. According to the two-hit
hypothesis of Garzoni et al. (21), early onset infections might be
estimated as a first hit in the development of NEC in preterm
infants. We, therefore, assume mild first hits in the development
of NEC in our preterm subgroup with an accordingly and
comparably mild clinical course of NEC. In contrast, the
intestinal necrosis and proof of bacteria in the intraoperative
swabs show an association with PDA- and CHD-NEC, and
here, an aggravated, advanced clinical course is observable.
We postulate that the two-hit hypothesis of Garzoni et al. (21)
cannot be applied in these cases. It can rather be hypothesized
that the continuous low intestinal perfusion, resulting in these
advanced cases, may be a further model of NEC pathology,
which underlines the differentiation of pathophysiology of NEC
in preterm infants and in infants with PDA/CHD.
Owing to the lack of a prospective patient-control study
design and the small population size of a monocentric study, our
results certainly have to be interpreted cautiously. Study design
was chosen on the basis of a limited, yet accurately diagnosed,
study population as we only included surgically treated NECs
with a histological confirmation of diagnosis. Additionally,
cases were only included in which we ensured the consistency
of surgeons of the department. Diagnostics and therapeutic
regimen of all patients were therefore comparable. Given these
known disadvantages of a small, monocentric population, we
see a clear advantage in this similarity and comparability of
therapy, surgical methods, and post-operative management in
the described cases. This might balance the fact that no real
consensus exists concerning indication, ideal timing, or type of
surgical procedure, which often leads to an NEC with significant
and potentially irreversible intestinal damage in cases of surgical
intervention (22, 23). Whereas Bell’s and Gordon’s criteria are
only considering clinical status of NEC patients, there are several
scores regarding an indication for surgical treatment (24–27).
Robinson et al. (28) propose a systematic review of surgical
NEC indications and timing for surgical treatment, contributing
new aspects on biomarkers and novel imaging methods
(such as near-infrared spectroscopy, measuring local tissue
hemoglobin oxygen saturation in patients). Multidisciplinary
research is still needed to improve the diagnostic and
therapeutic management and to confirm our results within larger
multicenter studies.
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CONCLUSION
Infants with reduced intestinal blood flow due to PDA
or CDH in addition to NEC showed more frequently
a positive bacterial culture of intraoperative swabs and
macroscopic intestinal necrosis compared to infants without
these risk factors. Additionally, a fulminant course of
NEC was significantly associated with NEC localization.
These observations in histologically confirmed NEC cases
demonstrate the hazard of reduced intestinal perfusion in
the pathophysiology of NEC: An early diagnosis and a timely
surgical intervention in NEC, especially in infants with PDA and
CDH, may be considered to avoid short bowel syndrome and
impaired outcome.
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